Extension of Time to File SOU

ORCHANA

Astellas Pharma Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97272428
LAW OFFICE ASSIGNED LAW OFFICE 106
MARK SECTION
MARK ORCHANA (see, http://uspto.report/TM/97272428/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ORCHANA
OWNER SECTION (current)
NAME Astellas Pharma Inc.
MAILING ADDRESS 5-1, Nihonbashi-Honcho 2-Chome, Chuo-Ku
CITY Tokyo
ZIP/POSTAL CODE 103-8411
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Japan
EMAIL XXXX
OWNER SECTION (proposed)
NAME Astellas Pharma Inc.
MAILING ADDRESS 5-1, Nihonbashi-Honcho 2-Chome, Chuo-Ku
CITY Tokyo
ZIP/POSTAL CODE 103-8411
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Japan
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Christian Morgan
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE chiusptomail@bakermckenzie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) christian.morgan@bakermckenzie.com; david.davis@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com
DOCKET/REFERENCE NUMBER 220078
CORRESPONDENCE INFORMATION (proposed)
NAME Christian Morgan
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE chiusptomail@bakermckenzie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) christian.morgan@bakermckenzie.com; david.davis@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com
DOCKET/REFERENCE NUMBER 220078
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Providing a website featuring temporary use of non-downloadable software for obtaining healthcare information, finding physicians and personal coaches in the field of women's health, and ordering pharmaceuticals, vitamins, and pregnancy, ovulation prediction, and diabetes monitoring test kits for home use
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Providing healthcare information
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 08/30/2022
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /Christopher Bolinger/
SIGNATORY'S NAME Christopher Bolinger
SIGNATORY'S POSITION Senior Director, IP Legal, Trademarks
DATE SIGNED 11/02/2022
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Fri Nov 04 11:27:33 ET 2022
TEAS STAMP USPTO/ESU-XXX.XXX.XX.XX-2
0221104112734418318-97272
428-800192e7ac2e381abdf78
8e1444cc9dd53e4688f57afc5
3d731332bc80d89bf72-DA-27
331897-202211011340328389
69



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: ORCHANA (see, http://uspto.report/TM/97272428/mark.png)
SERIAL NUMBER: 97272428

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Astellas Pharma Inc., having an address of
      5-1, Nihonbashi-Honcho 2-Chome, Chuo-Ku
      Tokyo, 103-8411
      Japan
      Email: XXXX
Proposed: Astellas Pharma Inc., having an address of
      5-1, Nihonbashi-Honcho 2-Chome, Chuo-Ku
      Tokyo, 103-8411
      Japan
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 08/30/2022.

For International Class 042:
Current identification: Providing a website featuring temporary use of non-downloadable software for obtaining healthcare information, finding physicians and personal coaches in the field of women's health, and ordering pharmaceuticals, vitamins, and pregnancy, ovulation prediction, and diabetes monitoring test kits for home use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 044:
Current identification: Providing healthcare information

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Christian Morgan
      PRIMARY EMAIL FOR CORRESPONDENCE: chiusptomail@bakermckenzie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): christian.morgan@bakermckenzie.com; david.davis@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com

Correspondence Information (proposed):
      Christian Morgan
      PRIMARY EMAIL FOR CORRESPONDENCE: chiusptomail@bakermckenzie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): christian.morgan@bakermckenzie.com; david.davis@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Christopher Bolinger/      Date Signed: 11/02/2022
Signatory's Name: Christopher Bolinger
Signatory's Position: Senior Director, IP Legal, Trademarks
Signature method: Sent to third party for signature

PAYMENT: 97272428
PAYMENT DATE: 11/04/2022

Serial Number: 97272428
Internet Transmission Date: Fri Nov 04 11:27:33 ET 2022
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.XX-2022110411273441
8318-97272428-800192e7ac2e381abdf788e144
4cc9dd53e4688f57afc53d731332bc80d89bf72-
DA-27331897-20221101134032838969




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed